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Abstract
Background: Reduced expression of developmentally important genes and tumor suppressors due to haploinsufficiency or
epigenetic suppression has been shown to contribute to the pathogenesis of various malignancies. However, methodology
that allows spatio-temporally knockdown of gene expression in various model organisms such as zebrafish has not been
well established, which largely limits the potential of zebrafish as a vertebrate model of human malignant disorders.
Principal Finding: Here, we report that multiple copies of small hairpin RNA (shRNA) are expressed from a single transcript
that mimics the natural microRNA-30e precursor (mir-shRNA). The mir-shRNA, when microinjected into zebrafish embryos,
induced an efficient knockdown of two developmentally essential genes chordin and a-catenin in a dose-controllable
fashion. Furthermore, we designed a novel cassette vector to simultaneously express an intronic mir-shRNA and a chimeric
red fluorescent protein driven by lineage-specific promoter, which efficiently reduced the expression of a chromosomally
integrated reporter gene and an endogenously expressed gata-1 gene in the developing erythroid progenitors and
hemangioblasts, respectively.
Significance: This methodology provides an invaluable tool to knockdown developmental important genes in a tissue-
specific manner or to establish animal models, in which the gene dosage is critically important in the pathogenesis of
human disorders. The strategy should be also applicable to other model organisms.
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Introduction
Understanding the development and disease-associated molec-
ular and cellular processes in model organisms has largely relied
on gene loss-of-function approaches. Homologous recombination-
mediated gene knockout has not yet been achieved in zebrafish,
due to the difficulty of generating embryonic stem cell line. The
generation of zebrafish knockout has instead taken use of
TILLING (targeting induced local lesions in genomes) strategy,
in which a library of ENU-mutagenized F1 animals are generated
and kept either as a cryopreserved sperm or as a living stock, and
the DNA of these animals is screened for genetic lesion in specific
exons [1]. Recently, heritable targeted gene disruption with
designed zinc-finger nucleases has been reported to inactivate
zebrafish golden, ntl and vascular endothelial growth factor-2 receptor genes
[2,3]. While these technologies will undoubtedly speed up the
dissection of signal transduction pathways/networks during
development and evolution, a conditional knockdown system with
stably titering down gene dosage in a tissue-specific fashion is
unavailable. This latter strategy is critically important toward
establishing zebrafish as a vertebrate model of human pathological
conditions and diseases [4], because increasing evidence has
demonstrated that haploinsufficiency and epigenetic suppression
of tumor suppressor genes, other than complete mutational
inactivation or permanent removal of genetic material from the
host genome, might be a preferred mechanism in promoting cell
transformation [5]. For instance, mice carrying hypomorphic Sfpi1
enhancer allele that reduces Pu.1 expression to 20% of normal
levels develop acute myeloid leukemia (AML), while a 50% or
even a 100% loss of Pu.1 expression only induc accumulation of
abnormal myeloid precursors [6]. Recent studies also indicate that
haploinsufficiency of RPS14 and even lower levels of a-catenin
expression ranging from 10 to 30% of normal contribute to the
pathogenesis of hematological malignant disorders [7,8]. These
data suggest that a narrow window of reduced expression of a
tumor suppressor is crucial for acute myeloid leukemia and solid
tumor development.
RNA interference (RNAi) using either chemically synthesized
small interfering RNAs (siRNA) or DNA-based vector systems
expressing small hairpin RNAs (shRNA) driven by RNA
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method to mediate sequence-specific, post-transcriptional silencing
of virtually any gene in various model organisms [9]. The shRNA-
mediated knockdown using either pol III or pol II promoter has
been utilized to knockdown gene expression in mammalian cells
and animals in a regulated fashion [10,11]. In combination with a
natural backbone of the primary miR-30 microRNA (miRNA),
higher amounts of synthetic shRNAs can be produced from the
pol III promoter than from the simple hairpin design [12]. This
miRNA-based shRNA (mir-shRNA) can also be produced by pol
II promoter in cultured cells [13,14], which offers several
advantages over the pol III promoter, including simultaneous
expression of several miR-shRNAs from a single polycistronic
transcript, and regulated or tissue-specific expression [15].
Unfortunately, a heritable and tissue-specific knockdown of gene
expression has not yet been developed in animal model organism
such as zebrafish, which largely restricts its genetic potential as a
vertebrate model of human disorders associated with reduced
expression of etiologic genes.
Here, we show that a miRNA-based shRNA (mir-shRNA),
when embedded in an intron of b-actin genomic fragment that is
in-frame linked to a fluorescent protein-coding reporter gene and
placed under the ubiquitous or tissue-specific pol II promoter, is
able to efficiently knockdown the expression of chromosomally
integrated and endogenous genes in a heritable and tissue- or cell-
specific fashion. Cells with reduced expression of targeted genes
can be visualized and dynamically traced owing to the expression
of the nontoxic actin-tagged fluorescent protein.
Results
Efficient Knockdown of Reporter Gene In Vivo by Mir-
shRNA
It has been previously shown that the 59 and 39 flanking
sequences of miRNA precursor are crucial for miRNA processing
and maturation [16], and the hairpin shRNA can be expressed
from a synthetic stem-loop precursor flanked by the 59 and 39
flanking sequences of either human miR-30 [14] or mouse miR-
155 gene [13]. We first identified zebrafish homologues of
mammalian miR-30 and miR-155 genes based on their sequence
identity (data not shown), and cloned both zebrafish pri-miR-30e
(409 bp) and pri-miR-155 (447 bp) genomic precursor sequences
into the pCS2
+ vector (Figure 1A. and data not shown).
Coinjection of in vitro synthesized capped pri-miR-30e mRNAs
and sensor EGFP mRNAs containing two tandem perfectly
complementary target sites (26PT for miR-30e binding) in its
39UTR (EGFP-26PT
mir30e; Figure 1B) into one-cell stage
embryos, resulted in a striking decrease of both EGFP fluorescence
and proteins (Figure 1C, D, right panels). As a control, injection of
miR-155 did not have any effects on the expression of EGFP-
26PT
mir30e (Figure 1B–D, left panels). Compared with the mir-
30e, injection of the capped miR-155 mRNAs showed less
efficiency to knockdown the EGFP sensor containing 26PT for
miR-155 binding (EGFP-26PT
mir155) (data not shown). The result
suggests that the 409 bp of pri-miR-30e precursor contains
flanking sequence capable of directing the production of
functionally mature miR-30e in vivo. We therefore used miR-30e
precursor as a backbone in the following experiments.
We next replaced the miR-30e stem-loop sequence with a
24 nt-long linker containing two Bbs I restriction sites that allowed
insertion of a synthesized shRNA
EGFP-ORF stem-loop and
preserved all flanking sequences intact (Figure 2A). The resultant
construct mir-shRNA
EGFP-ORF contained the same sequence
(including a di-nucleotide bugle [17]) as the native miR-30e
precursor, except that the strand of the mir-30 hairpin stem has
been replaced with the 22 nt-long sequences complementary to
EGFP open reading frame (ORF) at the position of 121–142
(Figure 1A and Figure 2A). Northern blot analysis showed that the
mir-shRNA
EGFP-ORF mRNAs, when injected into one-cell stage
embryo, gave rise to abundant mature shRNA
EGFP-ORF fragment
in 12 and 24 hours post fertilization (hpf) embryos (Figure 2B). To
test whether the mir-shRNA
EGFP-ORF was able to knockdown the
EGFP expression, we first microinjected the EGFP-ORF sensor
(containing the targeted site within its ORF; Figure 2C, top) with
either miR-30e precursor control or mir-shRNA
EGFP-ORF into
one-cell stage embryos (Figure 2D). Surprisingly, no obvious
knockdown effect was observed in 24 hpf embryos as evidenced by
fluorescence and Western blot analysis (Figure 2E, I, left panels),
although the same shRNA
EGFP-ORF under H1 promoter was able
to efficiently knockdown the EGFP expression in transfected 293T
cells (Figure S1).
We next tested additional sensors EGFP-39UTR-16INS and
EGFP-39UTR-26INS, in which one and two copies of the same
targeted site were introduced into the SV40-39UTR of EGFP
sensors (Figure 2C, middle). An obvious reduction on both EGFP
fluorescence and proteins was observed (Figure 2F, G; Figure 2I,
right panels). The same result was also obtained when the targeted
site was inserted into the 39UTR of the DsRed sensor (Figure 2C,
bottom; Figure 2H). In contrast, injection of miR-30e precursor
control had no detectable effects on EGFP expression (Figure 2E–
I, left panels). These results suggest that the targeted sites within
the 39UTR preferably conferred the knockdown effects by mir-
shRNAs, consistent with previous observations [18].
To further validate the knockdown effects conferred by 39UTR,
we designed two shRNAs, designated as mir-shRNA
EGFP-SV40-1
and mir-shRNA
EGFP-SV40-2, against the proximal and distal sites
within the SV40 of EGFP sensor (Figure S2A). Both mir-
shRNA
EGFP-SV40-1 and mir-shRNA
EGFP-SV40-2, when co-injected
with the capped EGFP-SV40 sensor into one-cell stage embryos,
were able to induce a dramatic knockdown of EGFP fluorescence
and proteins (Figure S2B, C). Furthermore, injection of either mir-
shRNA
EGFP-SV40-1 or mir-shRNA
EGFP-SV40-2, but not mir-
shRNA
EGFP-ORF mRNAs, suppressed the EGFP expression in
the hematopoietic intermediate cell mass (ICM) and forebrain in
22 hpf embryos derived from a transgenic line Tg(zgata-1:EGFP-
SV40) that stably expresses EGFP driven by gata-1 promoter
(Figure S2D,E).
Efficient Knockdown of Endogenous Target Genes by
Mir-shRNA
To test whether the mir-shRNA could knockdown endogenous
genes in zebrafish, we selected chordin and alpha-catenin that were
expressed during early embryogenesis. It has been shown that loss-
of-function of chordin results in embryonic ventralization with the
expansion of mesodermal hematopoietic tissue at the expanse of
neuroectodermal development [19]. Significantly reduced expres-
sion of alpha-catenin has been observed in the leukemia-initiating
cells of del(5q)-associated acute myeloid leukemia/myelodysplastic
syndrome and in the invasive solid tumors [8,20].
Because the local secondary structure and the free energy (DG)
of 39UTR might affect the accessibility by mir-shRNA [16], we
selected two sequences within the 39UTR of chordin gene, which
could be potentially targeted by mir-shRNA
chordin-39UTR-1 and
mir-shRNA
chordin-39UTR-2, respectively (Figure 3A). These two
sequences were selected with mFold software [21] based on the
DG of these sites and their flanking sequence (60 bp 59 and 39),
which the mir-shRNA
chordin-39UTR-1 appeared to have lower DG
than mir-shRNA
chordin-39UTR-2 (Figure 3B). The capped mir-
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chordin-39UTR-1 and mir-shRNA
chordin-39UTR-2 was individu-
ally microinjected into one-cell stage embryos and whole-mount in
situ hybridization (WISH) analysis with a dig-labeled antisense
probe was performed to evaluate the level of chordin transcripts.
While the chordin transcripts were appropriately detected in the
dorsal shield of wild-type or mir-shRNA
EGFP-ORF control-injected
embryos at 6 hpf as previously reported [22] (Figure 3C, left panel,
white arrowhead), a dramatic reduction of chordin transcripts
was observed in the embryos injected with 200 pg of mir-
shRNA
chordin-39UTR-1, but not with the same amount of mir-
shRNA
chordin-39UTR-2 likely due to its higher DG (3.7 v.s. 0.2 kcal/
mol) (Figure 3B and 3C, white arrowheads). As a result, an
enlarged blood ICM (Figure 3C, black arrowhead, n=61/99) with
increased gata-1 expression (black arrow) and partial loss of
neural tissues (white arrow) were observed only in mir-
shRNA
chordin-39UTR-1-injected embryos at 24 hpf, which were
comparable to the embryos injected with 0.8 ng of chordin-specific
morpholino oligonucleotides [19] (Figure 3D).
The mir-shRNA
a-catenin-39UTR-1 and mir-shRNA
a-catenin-39UTR-2
were also designed to target two regions within the 39UTR of
alpha-catenin gene (Figure 4A). WISH analysis showed that the
alpha-catenin was maternally expressed (data not shown) and
ubiquitously detected in wild type or control mir-shRNA
EGFP-ORF-
injected embryos at 8 hpf (Figure 4B, left panel). In contrast, a
significant reduction in the alpha-catenin transcripts was consistently
observed in the 8 hpf embryos injected with 160 pg of either mir-
shRNA
a-catenin-39UTR-1 or mir-shRNA
a-catenin-39UTR-2 (Figure 4B,
right panels). Consistently, quantitative Western blot analysis
showed that the alpha-catenin proteins were dramatically
decreased to 26% of normal level at 22 hpf (Figure 4C). To
determine whether the mir-shRNA
a-catenin-39UTR-1 can confer gene
knockdown in a dosage-dependent fashion, embryos were injected
with the same amount of duplex 06, duplex 16 and duplex 26,
which harboredzero, one and two copies of shRNA
a-catenin-39UTR-1,
respectively (Figure 4D, top). Northern and Western blot
analyses showed that as expected, injection of duplex 26
generated about one-fold more shRNAs (Figure 4D, bottom)
and one-fold less a-catenin proteins than injection of duplexes
16 and control at 22 hpf embryos (Figure 4D, bottom).
Consistently, injection of fourplex 46 also generated one-fold
more shRNAs than injection of fourplex 26 (Figure 4E),
suggesting that the a-catenin protein could be further reduced
(data not shown). Thus, the experimental design presented here
provided not only an efficient means to screen and identify mir-
Figure 1. Efficient inhibition of EGFP expression by zebrafish mir-30e precursor in vivo. (A, B) Diagram of zebrafish miR-30e precursor
sequence (A), and the EGFP sensor EGFP-26PT
mir30e containing two tandem perfectly complementary target sites for miR-30e binding (26PT) in its
39UTR (B, upper). The capped EGFP sensor mRNAs were co-injected with either miR-30e or miR-155 precursor mRNAs into one-cell stage embryos (B,
bottom). (C) A dramatic decrease of EGFP fluorescence in 24 hpf embryos co-injected with EGFP-26PT
mir30e sensor (10 pg) and miR-30e precursor
(50 pg). The DsRed mRNA was co-injected as an injection control (bottom panels). (D) Western blot analysis of 24 hpf embryos injected with EGFP-
26PT
mir30e sensor and miR-155 precursor or miR-30e precursor. The upper non-specific bands were shown as a loading control.
doi:10.1371/journal.pone.0006125.g001
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tool to titer down the gene dosage in a controllable manner.
Intronic Mir-shRNA Expression and Genetic Tractability
under Pol II Promoter
Natural miRNAs lying within the intron of protein-coding genes
have been shown to be co-transcribed with message mRNAs
under ubiquitous or tissue-specific pol II promoters [16]. We
designed a cytomegalovirus (CMV) prompter-driven expression
cassette in which the zebrafish b-actin genomic fragment
containing an intact exon 2 (123 base pairs), an intact intron 2
(364 base pairs) and the first 21-base pairs of exon 3, was in-frame
fused to the DsRed-Express (DsRed-EX) reporter followed by a
bovine growth hormone (BGH) poly (A) site as 39UTR (Figure 5A).
After injection of the plasmid cassette into one-cell stage embryos,
the injected embryos showed red fluorescence due to the
expression of the chimeric b-actin-DsRed protein, and no any
morphological and developmental abnormalities were observed
during embryogenesis (Figure 5B). The precise splicing of intron 2
from the b-actin-DsRed fusion gene in vivo was confirmed by
amplification of a predicted size of RT-PCR product and
subsequent sequencing (Figure 5C, D). Furthermore, co-injection
of the plasmid expression cassette carrying an introduced mir-
shRNA
EGFP-ORF or mir-shRNA
EGFP-SV40-1 at the Bgl II restriction
site within the intron 2, with the EGFP-SV40 reporter plasmid
(Figure 5E), resulted in a dramatic decrease of EGFP fluorescence
with correct splicing of the mir-shRNA-containing intron 2 in
22 hpf embryos (Figure 5F, G). The results provide a proof-of-
concept that knockdown of chromosomally integrated or endog-
enous genes under a tissue- or lineage-specific pol II promoter
might be feasible.
Heritable and Lineage-specific Knockdown of
Chromosomally Integrated and Endogenous Genes in
the Developing Erythroid Progenitors and
Hemangioblasts during Embryogenesis
We previously established a transgenic reporter line Tg(zgata-
1:EGFP-SV40) with stable expression of EGFP under the
erythroid-specific gata-1 promoter [23]. The transgenic line is
unique in that the EGFP expression can be detected in multiple
Figure 2. Knockdown of EGFP sensors by mir-shRNA in vivo. (A) Diagram of miRNA-based shRNA
EGFP-ORF (mir-shRNA
EGFP-ORF). The stem-loop
region of miR-30e precursor was replaced with chemically synthesized shRNA
EGFP-ORF oligonucleotides containing the same sequence as the miR-30e
stem-loop, except that the miR-30e hairpin stem was changed to the sequence that was complementary to the open reading frame (ORF) of EGFP
transcript. (B) Northern blot analysis of 12 and 24 hpf embryos injected with in vitro synthesized mir-shRNA
EGFP-ORF mRNAs. The U6 promoter-driven
expression of shRNA
EGFP-ORF in 293T cells was used as a positive control (left lanes). (C) Diagram of various sensors containing one or two copies of
binding sequence for mir-shRNA
EGFP-ORF within the ORF or the 39UTR. The 22-bp long binding sequence was inserted into the 39UTR-SV40 of either
EGFP or DsRed gene. (D) Individual capped sensor mRNAs was co-injected with either miR-30e precursor control or mir-shRNA
EGFP-ORF.( E–H)
Detection of EGFP and DsRed fluorescence in 24 hpf embryos injected with various sensor mRNAs. Red fluorescence was used as an injection control
in E, F and G, and green fluorescence as injection control in H.( I) Western blot analysis of 24 hpf embryos shown in panels E–G. The b-actin was
used as a loading control.
doi:10.1371/journal.pone.0006125.g002
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than in the erythropoietic ICM, which has also been observed in
previous transgenic line with the same gata-1 promoter [24]. Thus,
this line offers a unique advantage as a reporter line to detect mir-
shRNA mediated knockdown effects in multiple lineages and
tissues within an individual animal.
We screened and established 6 transgenic lines stably expressing
the intronic mir-shRNA
EGFP-SV40-1 under the same gata-1
promoter. One of the lines designated as Tg(zgata-1:mir-
shRNA
EGFP-SV40-1-actin-DsRed-BGH)
line 1 was selected to deter-
mine its knockdown potency because the DsRed fluorescent
proteins were also observed to be expressed in the same tissues as
the reporter line Tg(zgata-1:EGFP-SV40). When the homozygous
Tg(zgata-1:EGFP-SV40) reporter line was crossed to heterozygous
Tg(zgata-1:mir-shRNA
EGFP-SV40-1-actin-DsRed-BGH)
line 1 (Figure 6A),
421 (52.9%) and 375 (47.1%) of 796 F2 embryos collected from
multiple crosses were DsRed
+ and DsRed
2, respectively, suggesting
a dominant Mendelian ratio. The EGFP expression in both mRNA
and protein levels was dynamically evaluated in the DsRed
+ and
DsRed
2 sibling embryos at 24, 48 and 72 hpf. The results
demonstrated a significant reduction of EGFP fluorescence and
transcripts in the midbrain (MB), hindbrain (HB), dorsal neurons
(DN) and caudal hematopoietic tissue (CHT) only in the DsRed
+
embryos at 48 and 72 hpf, compared with the appropriate
expression of EGFP in the DsRed
2 siblings at the same
developmental stages (Figure 6B, C, arrows; Figure S3). Western
blot analysis further confirmed the results that a 45%, 58% and
62% of total EGFP protein was lost in the DsRed
+ embryos at 24,
48 and 72 hpf, respectively (Figure6D). The results indicate that the
mir-shRNA
EGFP-SV40-1 is able to mediate the cell subtype-specific
knockdown of a chromosomally integrated gene in a genetically
heritable manner.
To further test the knockdown effects on endogenous genes, we
selected an erythroid-specific gata-1 gene to evaluate the
knockdown the erythroid-specific gata-1 gene in the developing
hemangioblasts. A transgenic line Tg(zlmo2:mir-shRNA
gata-1-actin-
DsRed-BGH)
line 3 stably expressing the mir-shRNA
gata-1 under the
hemangioblastic lmo2 promoter [25,26] was established
(Figure 7A). Fluorescence and WISH analyses showed that the
DsRed fluorescence and transcripts were specifically expressed in
the lmo2-positive vascular endothelial cells and hematopoietic
progenitors at the ICM and posterior blood island (PBI) as
observed previously [25] (Figure 7A). As expected, a 50%
reduction of gata-1 transcripts was only observed in the PBI of
all DsRed
+ siblings at 22 hpf (Figure 7B, arrows). More
importantly, the pu.1 transcripts (a myeloid progenitor-specific
gene) were concomitantly increased in the same region of all
DsRed
+ sibling observed at 22 hpf (Figure 7C, arrows). The result
is consistent with previous observations that reciprocal negative
regulation between pu.1 and gata1 determines myeloid versus
erythroid fate [27].
Discussion
In this study, we have developed a novel methodology that uses
a microRNA-based shRNA (mir-shRNA) to reduce the dosage of a
given gene in a controllable and tissue-specific manner. Although
the miRNA-based shRNA knockdown strategy has been success-
fully used to mediate efficient and specific knockdown of genes in
vitro, its use in combination with cell- or tissue-specific pol II
Figure 3. Knockdown of endogenous cellular chordin expression. (A) Diagram of mir- shRNA
chordin-39UTR-1 and mir-shRNA
chordin-39UTR-2 against
the 39UTR of chordin gene, whose predicted secondary structure was shown at the bottom. Red brackets denoted the targeted regions. (B) Free-
energy of the targeted regions and corresponding flanking sequence predicted with mFold software. (C) Phenotypes of chordin-deficient embryos.
WISH analysis of chordin expression in the 6 hpf embryos injected with 200 pg of shRNA
EGFP-ORF (control), shRNA
chordin-39UTR-1 or shRNA
chordin-39UTR-2
mRNAs using a dig-labeled full-length 39UTR of chordin as probe (upper panels). A significantly enlarged ICM (black arrowhead) with a partial loss of
neural tissues (white arrow, 61/99) were observed in 24 hpf embryos injected with only shRNA
chordin-39UTR-1, but not with shRNA
chordin-39UTR-2 and
control (middle panels). A higher level of gata-1 expression was also detected in the shRNA
chordin-39UTR-1-injected embryos, compared to control or
shRNA
chordin-39UTR-2-injetced embryos (bottom panels). (D) Morphology of embryos injected with chordin morpholino oligonucleotides and its 4-base
pair mismatch control. Embryos at 6 hpf are dorsal view, and embryos at 24 hpf are lateral views with head to the left.
doi:10.1371/journal.pone.0006125.g003
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of the most frequently used microRNA sequence to direct the
processing and maturation of shRNA, because its stem sequence
could be substituted with exogenous sequences that match
different target genes and to produce 12 times more mature
shRNAs than simple hairpin designs [12,14], and its ability to
prevent interferon-stimulated gene expression and associated off-
target effects and toxicity in cultured cells and mouse brain
[17,28].
Although the sequences targeted by mir-shRNA in this study
are derived from 39UTR, the mir-shRNA should be able to target
sequences within other part of a given transcript such as the open
reading frame as described previously [12,17]. The observations
that the targeted site in the 39UTR, rather than in the ORF of
EGFP, confer robust knockdown effects by mir-shRNA
EGFP-ORF
(Figure 2), suggest that the mir-shRNA might preferably target
sequence in the 39UTR in vivo. Interestingly, the similar
phenomenon has also been observed in cultured Schneider S2
cells, although the underlying mechanism remains elusive [18]. On
the other hand, to optimize the site that mediate maximal
knockdown effects, two to three potential target sequences for a
given gene should be designed with mFold software and selected
based on the predicted secondary structure and DG. Furthermore,
as shown in Figure 4D and 4E, taking use of mir-shRNA duplex or
fourplex also provides a potential means to maximally knockdown
the target genes whose dosage can be regulated in a controllable
fashion.
The use of pol II promoter-driven mir-shRNA expression
cassette provides a unique advantage in that the cells or tissues
with reduced expression of target gene can be genetically traced
and visualized in the transparent zebrafish embryos, because of the
simultaneous expression of the chimeric red fluorescent protein, b-
actin-DsRed. Transgenic embryos and adults stably expressing this
chimeric fluorescent protein appear morphologically and devel-
opmentally normal and have been fertile for three generations,
suggesting a lack of detectable toxicity. Given the facts that
Figure 4. Knockdown of endogenous a-catenin expression. (A) Diagram of mir-shRNA
a-catenin-39UTR-1 and mir-shRNA
a-catenin-39UTR-2 against the
39UTR of a-catenin gene, whose predicted secondary structure was shown at the bottom. Red brackets denoted the targeted regions. (B) WISH
analysis of a-catenin expression in the 8 hpf embryos injected with 160 pg of either shRNA
EGFP-ORF, shRNA
a-catenin-39UTR-1 or shRNA
a-catenin-39UTR-2
mRNAs. (C) Quantitative Western blot analysis of a-catenin protein in 22 hpf embryos injected with shRNAs shown in panels B (5 embryos for each
lane). (D) Diagram of mir-shRNA duplexes carrying two copies of shRNA
EGFP-ORF (duplex 06), one copy for each shRNA
EGFP-ORF and shRNA
a-catenin-39UTR-1
(duplex 16), andtwocopiesof shRNA
a-catenin-39UTR-1 (duplex 26). Northern andWestern blot analysesof 22 hpf embryos injected with shRNAs06,1 6or
26as shown at the bottom (100 embryos for each line). The ribosomal 5S RNA and b-actin was used as a loading control, respectively. (E) Diagram of
mir-shRNA fourplexes carrying four copies of shRNA
EGFP-ORF (06), two copies for each shRNA
EGFP-ORF and shRNA
a-catenin-39UTR-1 (26), and four copies of
shRNA
a-catenin-39UTR-1 (46). Northern blot analysis of 22 hpf embryos injected with shRNAs 06,2 6or 46(100 embryos for each line). The ribosomal RNA
was used as a loading control.
doi:10.1371/journal.pone.0006125.g004
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tally important genes due to either epigenetic inactivation or
haploinsufficiency, contribute to the pathogenesis of myeloid
malignancies and tumorigenesis [6,8], the methodology described
in this study highly complements the recently reported zinc finger-
mediated gene knockout strategy in zebrafish, and provide an
Figure 5. Design of pol II promoter-driven knockdown construct. (A) Diagram of pol II-type promoter CMV driven-knockdown vector (CMV
promoter-actin-DsRed-BGH). DS: donor site; AS: acceptor site. The first 21-base pairs of exon 3 of zebrafish actin gene have been in-frame fused to the
DsRed fluorescent protein gene followed by a bovine growth hormone (BGH) sequence as 39UTR. (B) Red fluorescence was observed in 22 hpf
embryos injected with the plasmid shown in panel A.( C) RT-PCR analysis with total RNAs derived from 22 hpf embryos shown in panel B. The
primers used are indicated by horizontal arrows in panel A.( D) The sequence of RT-PCR product shown in pane C. Note that the entire intron 2 of the
actin gene has been spliced out (arrow). (E) The mir-shRNA
EGFP-SV40-1 was inserted into the intron 2 at the Bgl II site and co-injection with CMV-EGFP-
SV40 reporter plasmid. (F) Knockdown of EGFP fluorescence in the 24 hpf embryos co-injected with EGFP-SV40 reporter plasmid plus CMV promoter-
actin-DsRed-BGH plasmid carrying either mir-shRNA
EGFP-ORF or mir-shRNA
EGFP-SV40-1.( G) RT-PCR analysis of total RNAs derived from 22 hpf embryos
shown in panel F.
doi:10.1371/journal.pone.0006125.g005
Figure 6. Tissue-specific knockdown of chromosomally integrated EGFP expression. (A) Diagram of transgenic lines Tg(zgata-1:EGFP-
SV40) and Tg(zgata-1:mir-shRNA
EGFP-SV40-1-actin-DsRed-BGH)
line 1 under control of zebrafish gata-1 promoter. (B) Knockdown of EGFP fluorescence
was observed in the mid- and hindbrain of the DsRed
+, but not DsRed
2 F2 sibling at 48 hpf. Embryos are dorsal view with head to the left. (C)
Knockdown of EGFP fluorescence was observed in the dorsal neurons and caudal hematopoietic tissue of the DsRed
+, but not DsRed
2 F2 sibling at
72 hpf. MB: midbrain; HB: hindbrain; ys: yolk sac; DN: dorsal neurons; CHT: caudal hematopoietic tissue. Embryos are lateral view with head to the left.
(D) Western blot analysis of EGFP expression in the DsRed
2 and DsRed
+ F2 embryos at 24, 48 and 72 hpf. The a-tubulin protein was used as a loading
control.
doi:10.1371/journal.pone.0006125.g006
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tissues or cells in the model organisms. In combination with Cre-
loxP recombination and drug-inducible strategy [25,29], the pol II
promoter-driven mir-shRNA knockdown system could be further
optimized to prevent embryonic lethality from reduced expression
of the developmentally crucial genes and tumor suppressors.
Materials and Methods
Fish care
The maintenance, breeding and staging of zebrafish lines
(Tubingen and Shanghai) were performed as described previously
[30].
Cloning and plasmid construction
The precursor sequences of zebrafish mir30e (409 bp) and
mir155 (447 bp) were cloned from the genomic DNA of Tubingen
adult fish into the pCS2
+ vector. The 68-bp mir30e stem-loop
region was replaced with a linker sequence containing two Bbs I
sites using two-step PCR. The shRNA sequences were synthesized
as DNA oligonucleotides (Invitrogen) and inserted at the Bbs I
sites. The sensor sequences (26PT) were synthesized as DNA
oligonucleotides (Invitrogen) and placed into the 39UTR of the
pCS2
+-EGFP plasmid. The genomic sequence of zebrafish b-actin
containing an intact exon 2 and intron 2, and the first 21-bp of
exon 3 was in-frame infused to the open reading frame of DsRed-
39UTR BGH, and cloned into the pCS2
+ plasmid through BamH
I and EcoR I sites. The mir-shRNA was inserted into an
endogenous Bgl II site within the intron 2. The resultant intronic
mir-shRNA was then inserted downstream of the gata-1 promoter
or lmo2 promoter and cloned into the I-SceI-containing plasmid.
All primer sequences were available in Table S1.
Microinjection and establishment of transgenic zebrafish
line
All capped mRNAs were synthesized with SP6 mMessage
mMachine (Ambion) and microinjected into one-cell stage
embryos. The transgenic plasmids flanked by the I-SceI sites were
prepared with endotoxin-free miniprep kit (Axygen). Microinjec-
Figure 7. Tissue-specific knockdown of endogenous gata-1 expression. (A) The expression of DsRed fluorescence and transcripts
recapitulates the endogenous lmo2 expression pattern in the Tg(zlmo2:mir-shRNA
gata-1-actin-DsRed-BGH)
line 3. Note that stronger expression of
DsRed transcripts can be observed in the PBI region than in the ICM region. ICM: intermediate cell mass; PBI: posterior blood island. (B) WISH analysis
of gata-1 expression in the DsRed
2 and DsRed
+ F1 siblings at 22 hpf. Red star denotes the gata-1 staining in the developing kidney. (C) WISH analysis
of pu.1 expression in the DsRed
2 and DsRed
+ F1 siblings at 22 hpf. Note that the pu.1 staining is massively increased (arrow). All embryos are dorsal
view with head to the left.
doi:10.1371/journal.pone.0006125.g007
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solution containing 40 pg/nl of DNA, 0.56I-SceI buffers and
0.5 units/ml I-SceI meganuclease (New England Biolabs). Injected
embryos were raised to sexual maturity (F0 founders) and crossed
to wild-type zebrafish to generate F1 progeny, which were
screened for red fluorescent DsRed expression in the ICM at
24 hpf. The DsRed
+ F1 embryos were raised to adults to establish
the stable transgenic lines. Embryos were imaged using a Zeiss
SteREO Discovery V12 fluorescent stereomicroscope.
shRNA Northern blot analysis and RT-PCR
Total RNAs of embryos injected with capped mRNAs were
extracted with Trizol (Invitrogen), and separated on 12% of
UREA-PAGE gel. Northern blot was probed with dig-labeled
antisense probe, and visualized using DIG luminescent detection
kit for nucleic acids (Roche). RT-PCR was performed with One-
step RT-PCR kit (Qiagen) as previously described [30].
Whole-mount mRNA in situ hybridization
Whole-mount mRNA in situ hybridization was performed as
described previously [30]. Dig-labeled antisense probes of a-catenin
and chordin were generated from a 975-nt cDNA fragment
encoding N-terminal 325 aa of a-catenin, and entire 570 bp
39UTR, respectively.
Western blot analysis
Embryos were deyolked as described previously [31], and
dissolved directly by 26SDS-PAGE loading buffer (2 ml per
embryo). The samples were separated on 8% or 12% SDS-PAGE
gel (for detection of a-catenin and EGFP protein, respectively).
The antibodies against EGFP (Santa Cruz), a-catenin (BD), b-
actin (Sigma) and a-tubulin (Sigma) were diluted in 2% BSA as a
ratio of 1:1000, 1:500, 1:2000 and 1:10000, respectively.
Cell culture and transfection
HEK293T cells were cultured in Dulbecco’s modified Eagle’s
medium (Gibco) supplemented with 10% calf serum in an
atmosphere containing 5% CO2. H 1 pol III promoter-driven
shRNA and EGFP reporter (pEGFP-C1, Clontech) and DsRed
plasmid were cotransfected with a ratio (20:1:2) into the
HEK293T cells using the calcium phosphate method.
Supporting Information
Figure S1 Knockdown of EGFP gene by H1 pol III promoter
shRNA
EGFP-ORF in cultured 293T cells. (A) EGFP fluorescence
and (B) Western blot analysis of 48 hours post transfection.
Found at: doi:10.1371/journal.pone.0006125.s001 (5.36 MB TIF)
Figure S2 Transient knockdown of chromosomally integrated
EGFP gene. (A) Diagram of mir-shRNA
EGFP-SV40-1 and mir-
shRNA
EGFP-SV40-2 against the proximal and distal SV40-39UTR
of EGFP, respectively. (B) Detection of EGFP and DsRed
fluorescence in 24 hpf embryos injected with indicted mRNAs.
Red fluorescence was used as an injection control. (C) Western
blot analysis of 24 hpf embryos shown in panels B. The b-actin
was used as a loading control. (D) Detection of EGFP fluorescence
in the Tg(zgata-1:EGFP-SV40) transgenic embryos injected with
indicated mRNAs. The development and morphology of injected
embryos appeared to be normal (bottom panels). (E) Western blot
analysis of 24 hpf embryos shown in panels D. The a-tubulin was
used as a loading control.
Found at: doi:10.1371/journal.pone.0006125.s002 (9.92 MB TIF)
Figure S3 Tissue-specific knockdown of chromosomally inte-
grated EGFP transcripts. WISH analysis of EGFP and DsRed
mRNA expression in DsRed
2 (A), and DsRed
+ embryos (B) at
30 hpf. MB: midbrain; DN: dorsal neuron; PBI: posterior blood
island.
Found at: doi:10.1371/journal.pone.0006125.s003 (5.17 MB TIF)
Table S1
Found at: doi:10.1371/journal.pone.0006125.s004 (0.06 MB
DOC)
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